A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
This trial is a multi-center, double-blind, placebo-controlled, randomized study to evaluate
the efficacy and safety of AXS-05 compared to placebo for the treatment of agitation
associated with Alzheimer's disease.